TRIM44 and breast carcinoma: The reporter assay revealed TRIM44 knockdown significantly impaired NF-κB-mediated transcriptional activity stimulated by tumor necrosis factor α (TNFα) in both MCF-7 (Figure S2A) and MDA-MB-231 (Figure S2B) breast cancer cells.